-
-
-
-
-
-
-
CareDx to acquire cancer testing company Naveris for up to $260 million
-
-
-
-
-
-
-
CI Global Asset Management Announces Termination of CMVX and Completion of Fund Mergers
-
-
-
-
-
-
-
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
-
-
-
-
-
-
-
CareDx stock surges on the acquisition of MediGO
-
-
-
-
-
-
-
CareDx Announces $50 Million Stock Repurchase Program
-
-
-
-
-
-
-
CareDx Reports First Quarter 2022 Results
-
-
-
-
-
-
-
CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy
-
1,173,794 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

